Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.12 | 17.97 |
| PEG Ratio (TTM) | -0.05 | 2.29 |
| P/S Ratio (TTM) | 0.45 | 1.62 |
| P/B Ratio (TTM) | 0.71 | 3.15 |
| P/FCF Ratio (TTM) | 2.08 | 7.59 |
| Price to 5YR AVG Earnings Ratio | -80.03 | 18.94 |
| Price to 5YR AVG FCF Ratio | 10.09 | 11.96 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.17% | 3.96% |
| ROE (TTM) | 5.17% | 15.42% |
| Net Profit Margin (TTM) | 3.17% | 9.32% |
| ROIC 5YR AVG | 18.22% | 8.31% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 42.60% | -245.91% | -223.14% |
| Revenue | 3.05% | 0.33% | 0.93% |
| Net Income | 41.81% | -245.13% | -222.87% |
| Cash Flow | 71.30% | -32.82% | 2,725.05% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.53 | 0.76 |
| Quick Ratio (TTM) | 0.97 | 1.90 |
| D/E Ratio (TTM) | 0.16 | 0.35 |
| Interest Coverage (TTM) | 55.08 | 15.45 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | 0.50 | 1.45 |
| LTL to 5YR AVG FCF | 0.97 | 1.39 |
| Shares Outstanding Growth 5YR AVG | 0.12% | -1.64% |